Camel Milk in Pediatric Diabetic Ketoacidosis.

Renoprotective Effect of Camel Milk in Pediatric Diabetic Ketoacidosis: A focus on TLR-4/MAPK axis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201804003300204

Enrollment

100

Registered

2018-04-06

Start date

2017-09-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine Paediatrics Pediatric diabetic ketoacidosis

Interventions

insulin

insulin + camel milk

Healthy control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Newly diagnosed children with T1DM and DKA. The criteria for the diagnosis of T1DM who developed DKA are hyperglycaemia with blood glucose levels exceeding 11 mmol/L, heavy glycosuria (>55 mmol/L), ketonuria and metabolic acidosis (pH5% dehydration

Exclusion criteria

Exclusion criteria: Hypoglycemia, cardiovascular events, active cancers, pancreatitis, renal or acute infections

Design outcomes

Primary

Measure	Time frame
Inflammatory mediators (IL-1B, IL-6, IL-18);TLR-4, MAPK and NF-kB messenger RNA levels ;TLR-4 expression level, KIM-1 and Lipocalin 2;SOD	—

Countries

Egypt

Contacts

Public ContactWaleed Mohammed

Associate Professor of Clinical Chemistry, Cairo University Hospital

waleedalilab@yahoo.com00201158034894

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026